INFINIUM
Invest Now
Start SIP in
INFINIUM
Performance
- Low
- ₹308
- High
- ₹313
- 52 Week Low
- ₹178
- 52 Week High
- ₹393
- Open Price₹308
- Previous Close₹304
- Volume5,500
Investment Returns
- Over 1 Month + 31.82%
- Over 3 Month + 34.67%
- Over 6 Month -4.37%
- Over 1 Year + 40.74%
Smart Investing Starts Here Start SIP with Infinium Pharmachem for Steady Growth!
Infinium Pharmachem Fundamentals Fundamentals refer to the financial data that companies report on a quarterly or annual basis.
- P/E Ratio
- 38.4
- PEG Ratio
- -
- Market Cap Cr
- 434
- P/B Ratio
- 6.9
- Average True Range
- 12.58
- EPS
- 7.25
- Dividend Yield
- 0
- MACD Signal
- 14.14
- RSI
- 60.77
- MFI
- 42.98
Infinium Pharmachem Financials
Infinium Pharmachem Technicals
EMA & SMA
Current Price
₹311.75
+
8
(2.63%)

-
- Bearish Moving Average 0
-
- Bullish Moving Average 16
- 20 Day
- ₹288.68
- 50 Day
- ₹272.34
- 100 Day
- ₹270.74
- 200 Day
- ₹266.43
Resistance and Support
305.25
- R3 322.50
- R2 317.25
- R1 310.50
- S1 298.50
- S2 293.25
- S3 286.50
Infinium Pharmachem Corporate Actions - Bonus, Splits, Dividends
Date | Purpose | Remarks |
---|---|---|
2025-05-23 | Audited Results & Others | To consider other business matters. issue in the ratio of 1:1 of Rs. 10/-. |
2024-11-14 | Quarterly Results & Others | To consider other business matters. issue in the ratio of 1:1 of Rs. 10/-. |
2024-05-29 | Audited Results | |
2023-10-27 | Quarterly Results | |
2023-08-02 | Bonus issue |
Infinium Pharmachem F&O
About Infinium Pharmachem
- NSE Symbol
- INFINIUM
- BSE Symbol
- Managing Director
- Mr. Sanjaykumar Viththalbhai Patel
- ISIN
- INE0MRE01011
Similar Stocks to Infinium Pharmachem
Infinium Pharmachem FAQs
Infinium Pharmachem share price is ₹311 As on 20 May, 2025 | 11:12
The Market Cap of Infinium Pharmachem is ₹433.8 Cr As on 20 May, 2025 | 11:12
The P/E ratio of Infinium Pharmachem is 38.4 As on 20 May, 2025 | 11:12
The PB ratio of Infinium Pharmachem is 6.9 As on 20 May, 2025 | 11:12
Disclaimer: Investment in securities market are subject to market risks, read all the related documents carefully before investing. For detailed disclaimer please Click here.